Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
GlaxoSmithKline PLCGSK19.271.754.0825.8321.85%7.36%43.45$38.75$234.4957,090$33.96

Detail of GlaxoSmithKline PLC

 
CEO
Ms. Emma Natasha Walmsley
Employees
70212
Industry
Drug Manufacturers - General
Sector
Healthcare
Market cap
$55B

Company details

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
PI
TAX
NI
Revenue (Rev)
$31.31B
Cost of goods (CoG)
-$8.91B
Gross profit (GP)
$22.40B
Operating expense (OE)
-$18.63B
Research and development (R&D)
-$6.42B
General and administrative (G&A)
-$11.03B
Other (OTH)
-$1.19B
Operating income (OI)
$4.50B
Pretax income (PI)
$3.29B
Tax (TAX)
-$445.00M
Net income (NI)
$2.85B
GlaxoSmithKline PLC
GSK • XNYS • US
$33.96
-8.06 (-19.18%)
Stock vs Industry average
  • Industry average

Dividend yield
4.58%
Trailing annual dividend rate
$1.55697
Payout ratio
98.98%
EPS
$1.76
Margin profit
8.02%
52 week low
$33.235001
52 week high
$45.779999
50-day simple moving average
$0.00
200-day simple moving average
$38.75
Percent held by insiders
0.06%
Percent held by institutions
15.37%
Dividend yield
4.40%

Change of shares

Cash vs Debt

Comparison of selected companies

 
%
Price change
GSK -18.79%
eps change
GSK -103.88%